About Schering-Plough (India) Private Limited
Data last updated:
Schering-Plough (India) Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Fulford (India) Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 September 1989.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1989PTC053509.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.02 Lakh. It was led by directors Rehan Khan Abbas and Chand Berry.
Its last annual general meeting (AGM) was held on 07 June 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at No. 229 2nd Floor Trade Centre Premises Chsl Bandra Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.78 Lakh. For the same year it recorded a net profit of ₹1.63 Lakh (net margin 91.7%) and EBITDA of ₹1.63 Lakh (EBITDA margin 91.7%).
The last known website on record is merck.com.
Company details
Contact details
Schering-Plough (India) Private Limited's registered office is in Mumbai, Maharashtra. Its website is merck.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressNo. 229 2nd Floor Trade Centre Premises Chsl Bandra Kurla Complex Bandra (East), Mumbai, Maharashtra, India – 400051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Schering-Plough (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Schering-Plough (India) Private Limited
FY 2023 filings availableSchering-Plough (India) Private Limited reported revenue of ₹1.78 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 91.7% | ||||
| Net Profit Margin | 91.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Schering-Plough (India) Private Limited, buy the company report.
Board of directors of Schering-Plough (India) Private Limited
Schering-Plough (India) has 2 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rehan Khan Abbas Also directs: Metropolis Healthcare Limited, MSD Pharmaceuticals Private Limited | Director | 28 Feb 2022 | 4 Years 8 Months | As last reported |
| Chand Berry | Director | 11 Feb 2021 | 5 Years 9 Months | As last reported |
Peer comparison
Schering-Plough (India) Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Laila Formulations Private Limited | ₹1.8 Lakh (FY 2025) | Vijayawada, Andhra Pradesh, India | ||||
| Divye Life Sciences Private Limited | ₹1.79 Lakh (FY 2025) | -37.0% | Noida, Uttar Pradesh, India | |||
| Cyklo Pharma Chem Pvt Ltd | ₹1.79 Lakh (FY 2024) | -67.0% | Maharastra, Maharashtra, India | |||
| Ken Biotec Private Limited | ₹1.79 Lakh (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Hemline Flavours Private Limited | ₹1.79 Lakh (FY 2025) | -50.0% | Mumbai, Maharashtra, India | |||
| Schering-Plough (India) Private Limitedthis company | ₹1.78 Lakh (FY 2023) | ₹1.63 Lakh | 91.7% | Mumbai, Maharashtra, India | ||
| Biogenero Labs Private Limited | ₹1.77 Lakh (FY 2025) | -97.0% | Bangalore, Karnataka, India | |||
| Lavinia Life Sciences Private Limited | ₹1.76 Lakh (FY 2024) | -99.0% | Navi Mumbai, Maharashtra, India | |||
| Eu Med Services Private Limited | ₹1.75 Lakh (FY 2025) | -59.0% | Ernakulam, Kerala, India | |||
| Khilari Lifesciences Private Limited | ₹1.73 Lakh (FY 2024) | -100.0% | Khargar, Maharashtra, India | |||
| Sri Ramana Health Care Private Limited | ₹1.73 Lakh (FY 2016) | -98.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Schering-Plough (India) Private Limited, buy the company report.
Auditor
Schering-Plough (India) Private Limited is audited by SIDDHANT SHAH & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SIDDHANT SHAH & ASSOCIATES | FY 2020 | 143374W |
Shareholding
The shareholding of Schering-Plough (India) Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Schering-Plough (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Schering-Plough (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Schering-Plough (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Schering-Plough (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Schering-Plough (India) Private Limited has 16 board changes on record since 2007: 2 appointments and 14 cessations. The latest: Sameer Arunkumar Tamhane ceased to be Director on 30 Nov 2022.
7 earlier events are in the company report.
Frequently asked questions
Schering-Plough (India) has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Schering-Plough (India) was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 15 September 1989 and is registered under CIN U24230MH1989PTC053509. The company has been struck off by the Registrar of Companies and is no longer operational.
Schering-Plough (India) had 2 directors:
- Rehan Khan Abbas - Director
- Chand Berry - Director
The CIN (Corporate Identification Number) of Schering-Plough (India) is U24230MH1989PTC053509. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Schering-Plough (India) is at No. 229 2nd Floor Trade Centre Premises Chsl Bandra Kurla Complex Bandra East, Mumbai, Maharashtra, India – 400051.
Schering-Plough (India) was incorporated on 15 September 1989. It is registered with the Registrar of Companies, Mumbai.
Schering-Plough (India) can be reached through the website merck.com. Its registered office is in Mumbai, Maharashtra, India.
The latest financial statements of Schering-Plough (India) on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 07 June 2023. Year-wise statements from 2015 are in the company report.
Schering-Plough (India) operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
The peers of Schering-Plough (India) by revenue are Laila Formulations Private Limited, Divye Life Sciences Private Limited, Cyklo Pharma Chem Pvt Ltd, Ken Biotec Private Limited, Hemline Flavours Private Limited and 5 more, all in the Pharma industry (Formulations).
Sameer Arunkumar Tamhane ceased to be Director on 30 Nov 2022. Rehan Khan Abbas ceased to be Additional Director on 16 Sep 2022. Rehan Khan Abbas was appointed as Director on 28 Feb 2022. Schering-Plough (India) has 16 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
